The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Beryl Drugs Ltd

Beryl Drugs Ltd

BSE 524606 · NSE BERLDRG · ISIN INE415H01017 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹22.26

+0.50%

BSE close, 28 August 2026

Market cap

₹11.29 cr

0.5 cr shares · Micro cap

Free float

₹8.31 cr

as published

P/E · P/B

18.1× · 1.21×

EPS ₹1.23 · BV ₹18.40

FY25-26 rev / PAT

18.82 / 0.43

₹ cr, as filed

Filings, window

21

3 selected · 14%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹15.92 52-WK HIGH ₹30.00 ₹22.26 45% of range
Against 52-week high-25.8%
Against 52-week low+39.8%
Day change+0.50%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹1.23
Price / earnings18.10×
Price / book1.21×
Book value — derived, price ÷ P/B₹18.40
Return on equity6.72%
Operating margin8.88%
Net margin3.03%

Consistency check

P/B ÷ P/E, which must equal ROE
6.69%
ROE as published
6.72%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 7.30 0.22 0.44 8.88% 3.03%
Mar-26 · Q 5.13 0.56 1.11 26.15% 10.98%
FY25-26 18.82 0.43 0.30 12.89% 2.26%

Quarter on quarter

Revenue, quarter on quarter
+42.3%
Net profit, quarter on quarter
-60.7%
Operating margin, quarter on quarter
-1,727 bps

Disclosure profile 21 filings in the window

0 median 17.0 p75 · 25 sector max 52 21 64th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome2
Results1
Selected sub-total3
Procedural
AGM / EGM4
General3
Board Meeting2
SAST2
Annual Report1
Book Closure1
Compliance Certificate1
Newspaper Publication1
Other Update1
Record Date1
Trading Window1
Procedural sub-total18
Total21

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

21 filings · 3 selected · busiest 2026-09-03

Filing rhythm · the twelve most recent

2026-09-022026-10-07

SelectedProcedural

Filings

21 in the window · 11 earlier on record

  1. 7 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 7 October 2026 ·

    Other Update

    Compliance-57 (5) : intimation after the end of quarter

    NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026

    Others / 57 (5) : intimation after the end of quarter View filing →

  3. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    CLOSURE OF TRADING WINDOW

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

    AGM/EGM / AGM View filing →

  5. 29 September 2026 ·

    AGM / EGM

    PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

    PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING

    AGM/EGM / AGM View filing →

  6. 29 September 2026 ·

    General

    Approval For Inc rease In The Limit Of Material Related Party Transactions With M/S. Aminova Infusions Pvt. Ltd.

    considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.

    Company Update / General View filing →

  7. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    OUTCOME OF 33RD ANNUAL GENERAL MEETING

    AGM/EGM / AGM View filing →

  8. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    ANNUAL REPORT 2025-2026

    Others / Reg. 34 (1) Annual Report View filing →

  9. 3 September 2026 ·

    AGM / EGM

    33RD ANNUAL GENERAL MEETING NOTICE TO BE HELD ON 29TH SEPTEMBER, 2026 AT 11 A.M. AT KANCHAN PALACE COMMUNITY HAII, NIPANIA RING ROAD, INDORE

    33RD ANNUAL GENERAL MEETING NOTICE

    AGM/EGM / AGM View filing →

  10. 3 September 2026 ·

    General

    EVOTING DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

    EVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

    Company Update / General View filing →

  11. 3 September 2026 ·

    Record Date

    RECORD DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

    RECORD DATE

    Corp. Action / Record Date View filing →

  12. 2 September 2026 ·

    Book Closure

    ANNUAL BOOK CLOSURE

    INTIMATION OF ANNUAL BOOK CLOSURE

    Corp. Action / Book Closure View filing →

  13. 2 September 2026 ·

    Board Outcome

    Board Meeting Outcome for OUTCOME OF BOARD MEETING

    OUTCOME OF BOARD MEETING

    Board Meeting / Outcome of Board Meeting View filing →

  14. 27 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Approve Board Report And Other Matters Related To 33Rd Annual General Meeting Of The Company

    Beryl Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve approve board report and other ....

    Board Meeting / Board Meeting View filing →

  15. 20 August 2026 ·

    SAST

    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

    Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

  16. 19 August 2026 ·

    SAST

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

    Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

  17. 13 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

    Company Update / Newspaper Publication View filing →

  18. 11 August 2026 ·

    Results

    UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

    UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

    Result / Financial Results View filing →

  19. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for OUTCOME OF BOARD MEETING

    OUTCOME OF BOARD MEETING

    Board Meeting / Outcome of Board Meeting View filing →

  20. 5 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June, 2026

    Beryl Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited financial results ....

    Board Meeting / Board Meeting View filing →

  21. 21 July 2026 ·

    General

    Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.

    Company Update / General View filing →

RSS feed for Beryl Drugs Ltd · the 50 most recent filings